Esperas Pharma's Series A Round

Esperas Pharma raised a round of funding on April 13, 2015.

Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept. Esperas Pharma plans to begin clinical development as early as Q1-2016. Once cleared for clinical devel…

Articles about Esperas Pharma's Series A Round: